Market Research Reports and Industry Reports
instagram takipci kasma instagram takipci kasma atasehir escort maltepe escort kurtkoy escort maltepe escort alanya escort antalya escort konya escort tuzla escort pendik escort bostanci escort atasehir escort kadikoy escort kurtkoy escort tuzla escort erenkoy escort beykoz escort umraniye escort

Wounds - Pipeline Review, H2 2017

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Wounds - Pipeline Review, H2 2017

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Pipeline Review, H2 2017, provides an overview of the Wounds (Dermatology) pipeline landscape.

Wound is a breakdown in the protective function of the skin (the loss of continuity of epithelium) with or without loss of underlying connective tissue (i.e. muscle, bone, nerves) following injury to the skin or underlying tissues/ organs caused by surgery, a blow, a cut, chemicals, heat/ cold, friction/ shear force, pressure or as a result of disease, such as leg ulcers or carcinomas. Signs and symptoms include redness or red streaks on the skin surrounding the wound, increased swelling to tenderness at the wound site, pus-like drainage or a foul smell from the wound and body chills or fever.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Wounds - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Wounds (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Wounds (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Wounds and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 4, 8, 1, 56, 7 and 3 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 12 and 6 molecules, respectively.

Wounds (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Wounds (Dermatology).
- The pipeline guide reviews pipeline therapeutics for Wounds (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Wounds (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Wounds (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Wounds (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Wounds (Dermatology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Wounds (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2
Introduction 5
Wounds - Overview 6
Wounds - Therapeutics Development 7
Wounds - Therapeutics Assessment 21
Wounds - Companies Involved in Therapeutics Development 31
Wounds - Drug Profiles 49
Wounds - Dormant Projects 179
Wounds - Discontinued Products 185
Wounds - Product Development Milestones 186
Appendix 198

List Of Tables


Number of Products under Development for Wounds, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Companies, H2 2017 (Contd..2), H2 2017
Products under Development by Companies, H2 2017 (Contd..3), H2 2017
Products under Development by Companies, H2 2017 (Contd..4), H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Wounds - Pipeline by Advanced Inhalation Therapies (AIT) Ltd, H2 2017
Wounds - Pipeline by AlgiPharma AS, H2 2017
Wounds - Pipeline by Alliance Pharma Plc, H2 2017
Wounds - Pipeline by AmpliPhi Biosciences Corp, H2 2017
Wounds - Pipeline by AndroScience Corp, H2 2017
Wounds - Pipeline by Aridis Pharmaceuticals LLC, H2 2017
Wounds - Pipeline by Beech Tree Labs Inc, H2 2017
Wounds - Pipeline by Bioblue Technologies Inc, H2 2017
Wounds - Pipeline by Biotec Pharmacon ASA, H2 2017
Wounds - Pipeline by Cellphire Inc, H2 2017
Wounds - Pipeline by Chiesi Farmaceutici SpA, H2 2017
Wounds - Pipeline by CorMedix Inc, H2 2017
Wounds - Pipeline by CytoTools AG, H2 2017
Wounds - Pipeline by Dermala Inc, H2 2017
Wounds - Pipeline by Destiny Pharma Ltd, H2 2017
Wounds - Pipeline by Escape Therapeutics Inc, H2 2017
Wounds - Pipeline by Exicure Inc, H2 2017
Wounds - Pipeline by Exogenus Therapeutics SA, H2 2017
Wounds - Pipeline by FibroGen Inc, H2 2017
Wounds - Pipeline by Gene Signal International SA, H2 2017
Wounds - Pipeline by GlaxoSmithKline Plc, H2 2017
Wounds - Pipeline by IC-MedTech Inc, H2 2017
Wounds - Pipeline by Living Cell Technologies Ltd, H2 2017
Wounds - Pipeline by Madam Therapeutics BV, H2 2017
Wounds - Pipeline by MediWound Ltd, H2 2017
Wounds - Pipeline by Miragen Therapeutics Inc, H2 2017
Wounds - Pipeline by NatureWise Biotech & Medicals Corp, H2 2017
Wounds - Pipeline by Nippon Chemiphar Co Ltd, H2 2017
Wounds - Pipeline by Novan Inc, H2 2017
Wounds - Pipeline by Octapharma AG, H2 2017
Wounds - Pipeline by Omeros Corp, H2 2017
Wounds - Pipeline by Osiris Therapeutics Inc, H2 2017
Wounds - Pipeline by Pacific Northwest Biotechnology LLC, H2 2017
Wounds - Pipeline by ProMetic Life Sciences Inc, H2 2017
Wounds - Pipeline by SomaGenics Inc, H2 2017
Wounds - Pipeline by Stratatech Corp, H2 2017
Wounds - Pipeline by Synedgen Inc, H2 2017
Wounds - Pipeline by Thesan Pharmaceuticals Inc, H2 2017
Wounds - Pipeline by Topadur Pharma AG, H2 2017
Wounds - Pipeline by Traverse Biosciences Inc, H2 2017
Wounds - Pipeline by Tumorend LLC, H2 2017
Wounds - Pipeline by Vascular BioSciences, H2 2017
Wounds - Pipeline by viDA Therapeutics Inc, H2 2017
Wounds - Dormant Projects, H2 2017
Wounds - Dormant Projects, H2 2017 (Contd..1), H2 2017
Wounds - Dormant Projects, H2 2017 (Contd..2), H2 2017
Wounds - Dormant Projects, H2 2017 (Contd..3), H2 2017
Wounds - Dormant Projects, H2 2017 (Contd..4), H2 2017
Wounds - Dormant Projects, H2 2017 (Contd..5), H2 2017
Wounds - Discontinued Products, H2 2017

List Of Figures


Number of Products under Development for Wounds, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017

Wounds - Pipeline Review, H2 2017

Wounds - Pipeline Review, H2 2017Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Pipeline Review, H2 2017, provides an overview of the Wounds (Dermatology) pipeline landscape.Wound

USD 2000View Report

Wounds - Pipeline Review, H1 2017

Wounds - Pipeline Review, H1 2017Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Wounds - Pipeline Review, H1 2017, provides an overview of the Wounds (Dermatology) pipeline landscape.Wound

USD 2000View Report

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) - Pipeline Review, H2 2017

Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5) - Pipeline Review, H2 2017Gamma-Aminobutyric Acid Receptor Subunit Alpha 5 (GABA(A) Receptor Subunit Alpha 5 or GABRA5)

USD 3500View Report

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Pipeline Review, H2 2017

Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Pipeline Review, H2 2017According to the recently published report Neuronal Acetylcholine Receptor Subunit Alpha 4 (CHRNA4) - Pipeline Review, H2 2017; Neuronal

USD 3500View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprise Wide Licence    USD 6000
$ 2000

Reports Details

Published Date : Dec 2017
No. of Pages :209
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
Copyright © 2008 - 2018 Aarkstore.com | All rights reserved.